The global Clinical Trials Market is on a growth trajectory, with projections indicating it will reach $102.20 billion by 2031, representing a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031. This growth is underpinned by several factors, including a focus on rare diseases, the increasing adoption of personalized medicine, and growing research and development (R&D)...
English
Arabic
Français
Español
Português
Deutsch
Dutch
Italiano
Russian
Romaian